Gi Dynamics Inc (GIDYL) Return on Equity ROE from the first quarter 2021 to first quarter 2020 and annually, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Gi Dynamics Inc   (GIDYL)

Gi Dynamics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Gi Dynamics Inc in the first quarter 2021?
Due to the lack of equity, it was not possible to calculate Gi Dynamics Inc 's return on equity (ROE) in its first quarter 2021

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -11 -11 -12 -11 -18
Return On Equity (TTM) - - - - -
GIDYL's Total Ranking # # # # #
Equity (TTM) in Millions -1 -1 -4 -6 -3
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to GIDYL Management Effectiveness >> GIDYL's 5 Years Annual ROE >> Compare GIDYL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





GIDYL Annual Return On Equity (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions -1 -3 -3 -4 7
Y / Y Equity Change - - - - -62.81 %
Net Income in Millions -11 -17 -8 -11 -13
Y / Y Net Income Change - - - - -
Return On Equity - - - - -193.17 %

Back to GIDYL Management Effectiveness >> GIDYL's 5 Years Annual ROE >> Compare GIDYL ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GIDYL's' Return on Equity at Yahoo Finance
GIDYL's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GIDYL's Competitors
Subscribers only: Roe for Gi Dynamics Inc 's Suppliers
Subscribers only: Return On Equity for GIDYL's Customers




Companies with similar Return On Equity at Mar 31 2021, within Healthcare Sector ROE
Ginkgo Bioworks Holdings Inc   865.10 %
Ironwood Pharmaceuticals inc   402.46 %
Vyne Therapeutics Inc   375.26 %
Hca Healthcare Inc   291.06 %
Caremax Inc   248.14 %
Talkspace Inc   207.22 %
Mettler toledo International Inc   170.52 %
Agios Pharmaceuticals Inc   169.98 %
Halozyme Therapeutics Inc   154.14 %
Molecular Templates Inc   142.44 %
Hanger inc.  131.99 %
Idexx Laboratories Inc  131.57 %
Ovid Therapeutics Inc   128.18 %
Adicet Bio Inc   117.95 %
Dyne Therapeutics Inc   111.73 %
Eli Lilly And Company  109.81 %
Reflect Scientific Inc  107.75 %
Tenet Healthcare Corp  106.95 %
Orgenesis Inc   105.58 %
Fulgent Genetics Inc   101.39 %
Retractable Technologies Inc  94.44 %
Sunlink Health Systems Inc   93.17 %
Co diagnostics Inc   88.90 %
Quidelortho Corp  88.54 %
Tarsus Pharmaceuticals Inc   86.70 %

Date modified: 2026-09-08T15:10:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.